相关实验视频
Updated: Jul 4, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
确定预后影响,免疫治疗反应预测值,以及人类癌症中整合素亚单元α3 (ITGA3) 的潜在向化合物抑制剂
Jiawei Gui1,2, Lufei Yang1,3,4,5, Junzhe Liu1,3,4,5
1Department of Neurosurgery, The 2 Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, PR China.
Heliyon
|January 31, 2024
概括
综合素亚单元α3 (ITGA3) 在癌症进展和瘤微环境中起作用. 这项研究确定ITGA3作为预测免疫治疗反应和治疗点的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 综合素亚单元α3 (ITGA3) 与癌症的进展,转移和侵袭有关.
- ITGA3在瘤微环境 (TME),癌症预后和免疫治疗中的确切作用在很大程度上仍未被定义.
研究的目的:
- 进行ITGA3表达的综合癌症分析,其与临床结果的相关性,以及其在瘤免疫力和免疫治疗反应中的作用.
- 确定针对ITGA3.3的潜在治疗策略.
主要方法:
- 利用多种数据库和在线网络工具进行ITGA3.3的泛癌分析.
- 研究ITGA3表达和癌症患者预后,免疫相关途径,免疫透和免疫检查点之间的相关性.
- 分析了ITGA3对免疫治疗反应的预测价值,使用细胞因子治疗的样本和免疫治疗队列.
- 使用ConnectivityMap (CMap),CellMiner和AutoDock工具进行潜在的向化合物抑制剂和药物的选.用于分子对接.
主要成果:
- 在大多数瘤组织中,ITGA3异常表达和上调,与基因组变化和甲基化有关.
- ITGA3的表达与患者的预后,免疫路径,透和检查点有显著的相关性.
- ITGA3在预测瘤免疫疗法的反应方面表现出潜力.
- ITGA3可能调节TME并影响抗瘤免疫反应.
结论:
- ITGA3是预测免疫治疗反应的有希望的生物标志物,也是与癌症免疫治疗协同组合的潜在治疗标.
- 确定了针对ITGA3的向化合物抑制剂和敏感药物,这表明了潜在的治疗途径.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

